Clinical Pharmacology Study of CS-3150 Evaluation of the effect of repeated dose of itraconazole orally administered to healthy Japanese adult male on the pharmacokinetics of CS-3150
Phase of Trial: Phase I
Latest Information Update: 03 Jan 2017
At a glance
- Drugs Esaxerenone (Primary)
- Indications Diabetic nephropathies; Essential hypertension
- Focus Pharmacokinetics
- Sponsors Daiichi Sankyo Company
- 28 Nov 2016 Status changed from active, no longer recruiting to completed.
- 01 Aug 2016 Status changed from recruiting to active, no longer recruiting.
- 19 Jul 2016 Status changed from not yet recruiting to recruiting.